Published 20 days ago • loading... • Updated 20 days ago

ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa

Summary by diagnosticimaging.com

Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

diagnosticimaging.com

ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa

20 days ago

Read Full Article

Telix

Telix Highlights ProstACT Global, CUPID and STARLITE Therapy Studies in Prostate and Kidney Cancer at ASCO Annual Meeting 2025

Melbourne (Australia) and Indianapolis, IN (U.S.) | 30 May 2025 Telix today announces four accepted abstracts (three presentations) featuring the Company’s investigational therapeutic radiopharmaceutical programs at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Illinois from today, May 30, through June 3, 2025. Scott Tagawa MD, Professor of Medicine & Urology Weill Cornell Medicine (NY) will presen…

20 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right